Glucagon-induced PGC-1aplha4/PPARgamma promotes hepatic lipid storage and macrosteatosis in fasting and MASLD

Accession: MTBLS13087
Source / host: MetaboLights — EBI MetaboLights FTP
Disease relevance: MASLD / NAFLD / NASH (category: Metabolomic, subtype: metabolomics/lipidomics)
Modality / assay: metabolomics
Platform: metabolite profiling assay; mass spectrometry assay; Liquid Chromatography MS - positive - reverse phase
Organism: unspec
Size (indexed): 67.4 GB (72333771979 bytes)
Downloaded bytes: 1.1 MB (1119422 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
a_MTBLS13087_LC-MS_positive_reverse-phase_metabolite_profiling.txt35.2 KB488103b6550f2e5d…
i_Investigation.txt11.3 KB1e93285170b97226…
m_MTBLS13087_LC-MS_positive_reverse-phase_metabolite_profiling_v2_maf.tsv1.0 MB9b61e7aa3ba9ab3e…
s_MTBLS13087.txt16.0 KB080a24d61ac72e9e…

Index note: public study (ISA-Tab+MAF)

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T22:15:46Z.

About this dataset

This metabolite profiling assay; mass spectrometry assay; Liquid Chromatography MS - positive - reverse phase dataset provides single-cell gene expression from unspec liver samples, with disease state recorded as MASLD/NAFLD/NASH.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.